Source:http://linkedlifedata.com/resource/pubmed/id/16740259
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-9-15
|
pubmed:abstractText |
Endothelin-1 (ET-1), a potent vasoconstrictor, reduces local blood flow to levels that produce ischemic injury when injected directly into brain tissue. The purpose of this study was to compare 4 different methods of inducing focal ischemia with ET-1: (1) topical application to the forelimb motor region of the cortex, (2) intracerebral injection into the forelimb motor region of the cortex, (3) a combination of intracortical and intrastriatal injections and 4. injection of ET-1 adjacent to the middle cerebral artery (MCA). We examined the effect of delivery method and dose of ET-1 on lesion size, inter-animal variability and behavioral outcome on 3 separate tests of motor function and limb preference. We calculated success rate as the percentage of animals that survived surgery and developed a significant impairment (>20% decrease in performance post-surgery) in the staircase-reaching test. All 4 methods produced similar deficits in the staircase, balance beam, and cylinder tests, but the application of ET-1 adjacent to the MCA, though widely used, provided the lowest success rate. The combined cortical and striatal ET-1 produced a high success rate and consequently we examined cerebral blood flow (CBF), the apparent diffusion coefficient (ADC) and T2-weighted magnetic resonance imaging (MRI) changes for this model. We found that infarct volume measured using T2-weighted MRI correlated with histological measurements and that ADC and CBF together predicted which areas will suffer permanent injury. The combined cortical and striatal injection model offers a number of advantages for studies of recovery of function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0014-4886
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
201
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
324-34
|
pubmed:meshHeading |
pubmed-meshheading:16740259-Animals,
pubmed-meshheading:16740259-Behavior, Animal,
pubmed-meshheading:16740259-Brain Infarction,
pubmed-meshheading:16740259-Brain Ischemia,
pubmed-meshheading:16740259-Cerebral Cortex,
pubmed-meshheading:16740259-Corpus Striatum,
pubmed-meshheading:16740259-Drug Administration Routes,
pubmed-meshheading:16740259-Endothelin-1,
pubmed-meshheading:16740259-Injections,
pubmed-meshheading:16740259-Injections, Intraventricular,
pubmed-meshheading:16740259-Magnetic Resonance Imaging,
pubmed-meshheading:16740259-Male,
pubmed-meshheading:16740259-Motor Cortex,
pubmed-meshheading:16740259-Psychomotor Performance,
pubmed-meshheading:16740259-Rats,
pubmed-meshheading:16740259-Rats, Long-Evans
|
pubmed:year |
2006
|
pubmed:articleTitle |
An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat.
|
pubmed:affiliation |
Basic Medical Sciences, Faculty of Medicine, Memorial University, St John's, NL, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|